mTORC1 at the Lysosome

1. The Rag GTPase Tetramer

mTORC1 recruitment is mediated by a heterodimer of Rag GTPases: RagA or RagB (redundant) with RagC or RagD. The activating state is RagA/B-GTP + RagC/D-GDP. This active conformation binds the Raptor subunit of mTORC1 and brings it to the lysosomal surface. The opposite configuration (RagA/B-GDP + RagC/D-GTP) releases mTORC1 into the cytoplasm where it is inactive.

The Rags themselves are anchored to the lysosome by the Ragulator pentamer (LAMTOR1-5), tethered via an N-terminal myristoyl-palmitoyl modification of LAMTOR1 that inserts in the lysosomal outer leaflet.

2. Amino-Acid Sensing

Specific amino acids are sensed by dedicated sensors that control Rag activity:

• Leucine: sensed by Sestrin1/2/3 in the cytoplasm. Under leucine scarcity, Sestrin2 binds GATOR2 and indirectly inhibits Rag activity via GATOR1 (RagA/B GAP).
• Arginine: sensed by CASTOR1/2 in cytoplasm (similar GATOR1/2 pathway) and by SLC38A9 on the lysosomal surface (also functions as arginine exporter).
• S-adenosyl-methionine (SAM): sensed by SAMTOR (mediator of methionine availability).
• Lysosomal amino acids (from proteolysis within the lumen): detected by SLC38A9 and transmitted to Rags via V-ATPase/Ragulator interaction.
• Glucose/growth factors: signal via Rheb GTPase (separately anchored to lysosome). Rheb-GTP directly activates mTORC1 kinase once mTORC1 is recruited. TSC1/TSC2 tumour suppressor complex is Rheb GAP; loss-of-function (tuberous sclerosis) produces constitutive mTORC1 activation and a distinctive hamartoma phenotype.

The combinatorial architecture ensures mTORC1 activates only when nutrients, growth factors, and lysosomal function are all permissive.

3. mTORC1 Outputs

Active mTORC1 phosphorylates:

• S6K1: activates translation of TOP mRNAs (ribosomal proteins, translation factors).
• 4E-BP1: phosphorylation releases eIF4E for cap-dependent initiation (Ribosome course Module 1).
• ULK1: inhibitory phosphorylation, suppressing autophagy.
• TFEB/TFE3: cytoplasmic retention via 14-3-3 binding. Under mTORC1 inhibition, TFEB dephosphorylates and translocates to the nucleus, where it activates the CLEAR network of ~500 genes of lysosomal and autophagic biogenesis (Sardiello 2009; Settembre 2011). A single transcription factor expanding lysosomal capacity in response to lysosomal nutrient demand.
• SREBP: activation of lipid synthesis.
• HIF1α: translation under normoxia; coupling growth to glycolytic metabolism.

4. Rapamycin: The Discovery Drug

Rapamycin, discovered in soil bacteria from Easter Island (Rapa Nui) in 1975 by a Montreal team, immunosuppresses and is approved as sirolimus for transplant rejection. Rapamycin + FKBP12 binds the FRB domain of mTOR, allosterically inhibiting mTORC1 (but not mTORC2 acutely). It was a key tool in discovering mTORC1 biology.

Everolimus and temsirolimus are rapalogs approved for renal cell carcinoma, breast cancer (with aromatase inhibitors), and neuroendocrine tumours. ATP-competitive mTOR kinase inhibitors (PP242, MLN0128, RMC-5552) block both mTORC1 and mTORC2. Selective mTORC1 inhibitors (bi-steric RMC-5552, 3rd-gen rapalogs) are in development.

5. mTORC1 in Cancer & Aging

mTORC1 hyperactivation is near-universal in cancer: PI3K/AKT pathway activation, PTEN loss, TSC mutations, LKB1 loss all feed into it. Chronic mTORC1 activation also underlies tuberous sclerosis complex, Cowden syndrome, and cancers arising from PI3K/PTEN genetic lesions. Rapamycin extends lifespan in mice (the most robust intervention in the ITP cohort), C. elegans, yeast, and flies; the mechanism appears to be reduced anabolic burden and enhanced autophagy. Clinical trials of rapamycin/everolimus in healthy aging (Mannick 2014 improving influenza-vaccine responses in elderly; PEARL trial ongoing) are testing the hypothesis that mTORC1 tuning could modestly extend human healthspan.

6. mTORC1 and the Lysosome Is a Feedback Loop

Elegant coupling: under starvation, mTORC1 goes inactive, TFEB enters the nucleus, lysosomal biogenesis increases, lysosomes fuse with autophagosomes, catabolism generates amino acids, SLC38A9 + v-ATPase sense them, Rag activation reassembles, mTORC1 reactivates, TFEB re-exports, lysosomal biogenesis subsides. The lysosome is simultaneously the sensor and the effector of this homeostatic control loop. This insight — lysosome as signalling hub, not just disposal unit — is the headline of 21st-century lysosome biology.